(Q43624775)

25 November 2017

title

Effect of corticosteroid therapy on serum and CSF malondialdehyde and antioxidant proteins in multiple sclerosis (English)

1 reference

25 November 2017

0 references

Keles MS

1

1 reference

25 November 2017

Taysi S

2

1 reference

25 November 2017

Sen N

3

1 reference

25 November 2017

Aksoy H

4

1 reference

25 November 2017

Akçay F

5

1 reference

25 November 2017

publication date

1 May 2001

1 reference

Canadian Journal of Neurological Sciences

25 November 2017

published in

1 reference

25 November 2017

volume

28

1 reference

25 November 2017

issue

2

1 reference

25 November 2017

page(s)

141-143

1 reference

Antioxidant effect of caeruloplasmin on microsomal lipid peroxidation

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100052823

7 January 2021

Mechanisms in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100052823

7 January 2021

The role of ceruloplasmin in iron metabolism

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100052823

7 January 2021

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100052823

7 January 2021

The inhibition of lipid autoxidation by human caeruloplasmin

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100052823

7 January 2021

Lipid peroxidation products and antioxidant proteins in plasma and cerebrospinal fluid from multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100052823

7 January 2021

Low density lipoprotein uptake by macrophages in multiple sclerosis plaques: implications for pathogenesis

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100052823

7 January 2021

10.1017/S0317167100052823

Identifiers

DOI

0 references

1 reference